OBP-702 suppressed not only cancer cells but also CAFs by inducing wild-type p53. Further, i.p. administration of OBP-702 and PTX showed significant antitumor effects against peritoneal metastasis in an orthotopic xenograft model by suppressing both cancer cells and CAFs. This evidence concerns the gene TP53 and cancer.